AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions. Contacts concerning Food and Drug Admnistration (FDA) authority to manage drug shortages. Communication to FDA on withdrawal of unapproved drugs, presentation at FDA Public Workshop on drug shortages. Labor-Health and Human Services appropriations, fiscal year 2011; support for Administration's request for FDA funding. Contacts concerning funding for section 3503 of the Affordable Care Act (P.L. 111-148)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KAREN NOONAN | — |
| CHRISTOPHER J TOPOLESKI | — |
Medicare/Medicaid MMM
Communication with Centers for Medicare and Medicaid Services regarding hospital outpatient prospective payment system, influenza vaccines, conditions of participation, Innovation Center, funding for specialized pharmacy residency programs, and direct reimbursement under the Medicare program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KAREN NOONAN | — |
| CHRISTOPHER J TOPOLESKI | — |
Pharmacy PHA
Comments to the Health Resources and Services Administration on the 340B Drug Discount Program and the procurement of orphan drugs under the program. Submitted letter of support for H.R. 2674, the 340B Improvement Act of 2011.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KAREN NOONAN | — |
| CHRISTOPHER J TOPOLESKI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.